“…A level of total PSA of 4.0 ng/mL has traditionally been used as the threshold for consideration of a prostate biopsy, recognizing that 30-35% of men in the intermediate PSA range (4-10 ng/mL) will be found to have cancer (Oncology et al 2007). There have been several reports on clinical variables, which may improve the speciWcity in the early detection of CaP, including PSA density (Benson et al 1992), PSA density of the transition zone (Zlotta et al 1997), age-speciWc reference ranges (Oesterling et al 1993), PSA molecular forms (Catalona et al 1995;Okihara et al 2002), PSA velocity (Carter et al 1992), PSA doubling time (Schmid et al 1993) as well as transrectal biopsy techniques (Eskew et al 1997;Babaian et al 2000).…”